Gene-expression signature predicts autoimmune toxicity in metastatic melanoma
Objectives To identify predictive gene-expression signatures for immune-related adverse events (irAEs) in patients with melanoma treated with anti-PD-1 inhibitors, in the adjuvant therapy (AT) and first-line therapy (FLT).Methods This retrospective study analyzed baseline whole-blood gene expression...
| Published in: | Journal for ImmunoTherapy of Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-07-01
|
| Online Access: | https://jitc.bmj.com/content/13/7/e011315.full |
